<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To determine whether the clustered features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> precede the 7 year incidence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we examined 6182 Japanese male office workers aged 35-59 years without any history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The 5588 subjects without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> also constituted the nondiabetic cohort, and were re-examined over seven successive years </plain></SENT>
<SENT sid="2" pm="."><plain>Components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> included glycemic disorder (type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> for the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> for the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>), systemic <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, and elevated white blood cell (WBC) count </plain></SENT>
<SENT sid="3" pm="."><plain>After controlling for age, family history of <z:mp ids='MP_0002055'>diabetes</z:mp>, alcohol intake, and cigarette smoking, the multivariate-adjusted relative risk of incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> compared with absence of components was 3.18, 3.48, 12.55, and 14.15 (P for trend &lt;0.001), for the presence of 1,2,3, and &gt; or =4 components, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The corresponding relative risks of incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were 1.92, 4.36, 6.44, and 15.08 (P for trend &lt;0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>In both non-smokers and current smokers, the multivariate-adjusted relative risks of incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> increased as the number of components increased (P for trend &lt;0.001 for <z:hpo ids='HP_0000001'>all</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>Our findings indicate that clustered features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> are closely associated with development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in middle-aged Japanese </plain></SENT>
</text></document>